» Articles » PMID: 31001150

Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness

Abstract

Vitamin D inadequacy or deficiency (VDID) has been reported in a high percentage of otherwise healthy individuals. Factors that may contribute to the high prevalence of VDID in people with mental disorders include diet low in vitamin D, poor sunlight exposure, decrease in cutaneous vitamin D synthesis, intake of certain medications, poor mobility, excessive alcohol intake, and tobacco smoking. VDID has been correlated to a host of adverse conditions, including rickets, osteoporosis, osteomalacia, muscle diseases, depression, cognitive dysfunction, and even certain cancers. The purpose of this study was to report the prevalence and correlates of vitamin D inadequacy in a sample of 290 psychiatric patients admitted to inpatient or day hospital treatment at the University of Siena Medical Center. We retrospectively evaluated the prevalence of VDID in 290 psychiatric inpatients' medical records during the year 2017 and evaluated the correlates of VDID in patients with mental illness. Two hundred and seventy two out of two hundred and ninety patients (94%) showed VDID. Physical activity and regular diet were positively correlated with vitamin D levels whereas age, tobacco smoking, PTH, alkaline phosphatase levels were negatively correlated. Statistically significant differences were found among smokers and non-smokers in all study groups. VDID was highly prevalent in our sample. In addition to vitamin D supplementation, psychosocial intervention able to promote and help sustain physical activity, appropriate diet, quitting smoking and sensible sun exposure to prevent and treat VDID in patients with mental health should be implemented, tested, and introduced in our clinical practice.

Citing Articles

Comprehensive Sex-Stratified Genetic Analysis of 28 Blood Biomarkers and Depression Reveals a Significant Association between Depression and Low Levels of Total Protein in Females.

Kiewa J, Meltzer-Brody S, Milgrom J, Guintivano J, Hickie I, Whiteman D Complex Psychiatry. 2024; 10(1-4):19-34.

PMID: 38584764 PMC: 10997320. DOI: 10.1159/000538058.


Tracing vitamins on the long non-coding lane of the transcriptome: vitamin regulation of LncRNAs.

Yazarlou F, Alizadeh F, Lipovich L, Giordo R, Ghafouri-Fard S Genes Nutr. 2024; 19(1):5.

PMID: 38475720 PMC: 10935982. DOI: 10.1186/s12263-024-00739-4.


A positive association between food insecurity and the prevalence of overactive bladder in U.S. adults.

Xiao Y, Yin S, Bai Y, Wang J, Cui J, Yang Y Front Nutr. 2024; 10:1329687.

PMID: 38370980 PMC: 10870421. DOI: 10.3389/fnut.2023.1329687.


Severe Vitamin D Deficiency-A Possible Cause of Resistance to Treatment in Psychiatric Pathology.

Ciobanu A, Petrescu C, Anghele C, Manea M, Ciobanu C, Petrescu D Medicina (Kaunas). 2023; 59(12).

PMID: 38138159 PMC: 10744484. DOI: 10.3390/medicina59122056.


The Influence of Vitamin D Status on Cognitive Ability in Patients with Bipolar Disorder and Healthy Controls.

Leser B, Dalkner N, Tmava-Berisha A, Fellendorf F, Unterrainer H, Stross T Nutrients. 2023; 15(19).

PMID: 37836395 PMC: 10574501. DOI: 10.3390/nu15194111.


References
1.
Brot C, Jorgensen N, Sorensen O . The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999; 53(12):920-6. DOI: 10.1038/sj.ejcn.1600870. View

2.
Walbert T, Jirikowski G, Prufer K . Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. Horm Metab Res. 2001; 33(9):525-31. DOI: 10.1055/s-2001-17210. View

3.
Gordon C, DePeter K, Feldman H, Grace E, Emans S . Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004; 158(6):531-7. DOI: 10.1001/archpedi.158.6.531. View

4.
Kalueff A, Eremin K, Tuohimaa P . Mechanisms of neuroprotective action of vitamin D(3). Biochemistry (Mosc). 2004; 69(7):738-41. DOI: 10.1023/b:biry.0000040196.65686.2f. View

5.
Kalueff A, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P . The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord Drug Targets. 2006; 5(3):363-71. DOI: 10.2174/187152706784111506. View